Dilaudid
NDC Package 0074-2452-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dilaudid is a medication used to help relieve moderate to severe pain. Marketed by Abbvie Inc., this product is identified by NDC 0074-2452 and is authorized under FDA application NDA019892.

Identification & Billing

NDC Package Code
0074-2452-02
Package Description
473 mL in 1 BOTTLE
Product Code
0074-2452
11-Digit Billing Format
00074245202

Clinical Specifications

Proprietary Name
Dilaudid
Dosage Form
-
Usage Information
This medication is used to help relieve moderate to severe pain. Hydromorphone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Regulatory & Marketing

Labeler Name
Abbvie Inc.
FDA Application #
NDA019892
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-07-1992
End Marketing Date
12-31-2008
Listing Expiration
12-31-2008
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0074-2452-02 identifies a specific commercial package of 473 ml in 1 bottle of Dilaudid, labeled by Abbvie Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Abbvie Inc. on December 07, 1992. The current certification is valid through December 31, 2008.

What are the primary indications for this medication?

This medication is used to help relieve moderate to severe pain. Hydromorphone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

How is this Abbvie Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00074245202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0074-2452-02
11-Digit CMS (5-4-2)
00074-2452-02

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.